London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.

Clinical outcome of toric implantable collamer lenses in patients with stable keratoconus post corneal collagen cross-linking

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Posterior chamber Phakic IOLS for correction of Myopia

Session Date/Time: Monday 15/09/2014 | 08:00-10:30

Paper Time: 09:55

Venue: Capital Hall B

First Author: : S.Goel INDIA

Co Author(s): :    S. Mukherjee   H. Parashar           

Abstract Details


To evaluate the safety & clinical outcome of toric Implantable collamer lenses (ICL) in patients of stable keratoconus.


Anand Eye Hospital, Jaipur, India


Prospective, non randomised, non comparative, interventional study of ICL implantation in 17 eyes of 11 patients with keratoconus was carried out from January 2012 to December 2013 .Progressive keratoconus was first stabilized with collagen cross linkage.once stability established ,and minimum interval of one year was kept between the stabilization procedure and ICL implantation. Data was collected pre op, at 3 months and at 6 months follow up visit after ICL implantation.


Patients were in the age group of 19 – 42 years with majority (41.46%) in the age group of 24 – 28 years. Preop refractive error varied from spherical equivalent of -1.62D to -25D, with mean spherical equivalent of – 9.75D. Post surgery V/A showed 1 line improvement in 8 eyes, 2 line improvement in 5 eyes, 3 line & 4 line improvement in 2 eyes each. V/A was status quo in 14 eyes and 2 (2.99%) eyes showed deterioration of V/A against BCVA. 1 eye had secondary glaucoma .


Implantation of ICL following stabilization of keratoconus with C3R is a safe & effective option. Hence ICL is a much awaited definitive and rewarding form of treatment in patients with keratoconus.

Financial Interest:


Back to previous